Patient characteristics (n = 20)
| . | No. . | % . |
|---|---|---|
| Sex | ||
| Male | 10 | 50 |
| Female | 10 | 50 |
| Race | ||
| White | 17 | 85 |
| African-American | 2 | 10 |
| Asian | 1 | 5 |
| Age (yr) | ||
| Median 58.5 | ||
| Range 47–78 | ||
| Performance status | ||
| 0 | 8 | 40 |
| 1 | 9 | 45 |
| 2 | 3 | 15 |
| Histology | ||
| Adenocarcinoma | 11 | 55 |
| Large cell | 3 | 15 |
| Bronchioloalveolar carcinoma | 1 | 5 |
| Squamous | 1 | 5 |
| Poorly differentiated or unspecified | 4 | 20 |
| Metastatic disease sitesa | ||
| Liver | 5 | 25 |
| Bone | 9 | 45 |
| Adrenal | 1 | 5 |
| Lung/Pleura | 14 | 70 |
| . | No. . | % . |
|---|---|---|
| Sex | ||
| Male | 10 | 50 |
| Female | 10 | 50 |
| Race | ||
| White | 17 | 85 |
| African-American | 2 | 10 |
| Asian | 1 | 5 |
| Age (yr) | ||
| Median 58.5 | ||
| Range 47–78 | ||
| Performance status | ||
| 0 | 8 | 40 |
| 1 | 9 | 45 |
| 2 | 3 | 15 |
| Histology | ||
| Adenocarcinoma | 11 | 55 |
| Large cell | 3 | 15 |
| Bronchioloalveolar carcinoma | 1 | 5 |
| Squamous | 1 | 5 |
| Poorly differentiated or unspecified | 4 | 20 |
| Metastatic disease sitesa | ||
| Liver | 5 | 25 |
| Bone | 9 | 45 |
| Adrenal | 1 | 5 |
| Lung/Pleura | 14 | 70 |
All patients enrolled had stage IV disease. Patients with central nervous system metastases were ineligible. Patients with large pleural effusions were not enrolled until the fluid was drained ± pleurodesis.